Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spyre Therapeutics (SYRE) Q1 2019 Earnings
SYRE
7
May
Expected
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-15.5
-10.45
-5.41
-0.36
Details
Expected EPS
-0.55
Actual EPS
-14.75
Surprise EPS
-14.2
Surprise Percent
+2,581.82%
Description
Spyre Therapeutics (SYRE) has reported earnings of -14.75 per share for Q1 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login